Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

作者: Natalie A. Wheeler , Babette Fuss

DOI: 10.1016/J.EXPNEUROL.2016.03.019

关键词:

摘要: There is an increasing number of neurologic disorders found to be associated with loss and/or dysfunction the CNS myelin sheath, ranging from classic demyelinating disease, multiple sclerosis, through injury, neuropsychiatric diseases. The disabling burden these diseases has sparked a growing interest in gaining better understanding molecular mechanisms regulating differentiation myelinating cells CNS, oligodendrocytes (OLGs), and process (re)myelination. In this context, importance extracellular milieu becoming increasingly recognized. Under pathological conditions, changes inhibitory as well permissive/promotional cues are thought lead overall environment that obstructive for regeneration sheath. Given general view remyelination is, even though limited human, natural response demyelination, targeting pathologically 'dysregulated' their downstream pathways regarded promising approach toward enhancement by endogenous (or if necessary transplanted) OLG progenitor cells. review, we will introduce have been implicated modulation These can soluble, part matrix (ECM) or mediators cell-cell interactions. Their roles regard potential therapeutic intervention discussed.

参考文章(466)
Raymond A. Sobel, Azam S. Ahmed, White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis. Journal of Neuropathology and Experimental Neurology. ,vol. 60, pp. 1198- 1207 ,(2001) , 10.1093/JNEN/60.12.1198
Raphael Kopan, Notch: a membrane-bound transcription factor. Journal of Cell Science. ,vol. 115, pp. 1095- 1097 ,(2002) , 10.1242/JCS.115.6.1095
W. F. Blakemore, R. J. M. Franklin, Remyelination in Experimental Models of Toxin-Induced Demyelination Current Topics in Microbiology and Immunology. ,vol. 318, pp. 193- 212 ,(2008) , 10.1007/978-3-540-73677-6_8
Catherine Lubetzki, Bruno Stankoff, Demyelination in multiple sclerosis Handbook of Clinical Neurology. ,vol. 122, pp. 89- 99 ,(2014) , 10.1016/B978-0-444-52001-2.00004-2
Vladimir Berezin, Peter S. Walmod, Mikhail Filippov, Alexander Dityatev, Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases. Progress in Brain Research. ,vol. 214, pp. 353- 388 ,(2014) , 10.1016/B978-0-444-63486-3.00015-3
Robin L. Haynes, Rebecca D. Folkerth, Rachael J. Keefe, Iyue Sung, Luke I. Swzeda, Paul A. Rosenberg, Joseph J. Volpe, Hannah C. Kinney, Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. Journal of Neuropathology and Experimental Neurology. ,vol. 62, pp. 441- 450 ,(2003) , 10.1093/JNEN/62.5.441
Karin Hagemeier, Tanja Kuhlmann, Wolfgang Brück, Multiple sclerosis - remyelination failure as a cause of disease progression. Histology and Histopathology. ,vol. 27, pp. 277- 287 ,(2012) , 10.14670/HH-27.277
Sarah Moyon, Jialiang Liang, Patrizia Casaccia, Epigenetics in NG2 glia cells. Brain Research. ,vol. 1638, pp. 183- 198 ,(2016) , 10.1016/J.BRAINRES.2015.06.009
David Purger, Erin M. Gibson, Michelle Monje, Myelin plasticity in the central nervous system. Neuropharmacology. ,vol. 110, pp. 563- 573 ,(2016) , 10.1016/J.NEUROPHARM.2015.08.001
Kenneth A. Jacobson, New paradigms in GPCR drug discovery Biochemical Pharmacology. ,vol. 98, pp. 541- 555 ,(2015) , 10.1016/J.BCP.2015.08.085